Published in Dig Dis Sci on March 01, 1986
Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut (2007) 3.87
Twenty four hour manometric recording of colonic motor activity in healthy man. Gut (1987) 2.75
The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria. BMC Gastroenterol (2008) 1.49
Increased segmental activity and intraluminal pressures in the sigmoid colon of patients with the irritable bowel syndrome. Gut (1989) 1.45
The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers. Gut (2002) 1.39
Colonic mass movements in idiopathic chronic constipation. Gut (1988) 1.36
An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome. Gut (2001) 1.26
Gastroparesis and small bowel dysmotility in irritable bowel syndrome. Dig Dis Sci (1997) 1.09
Asian motility studies in irritable bowel syndrome. J Neurogastroenterol Motil (2010) 1.04
Functional dyspepsia and irritable bowel syndrome, are they different entities and does it matter? World J Gastroenterol (2006) 1.03
Is irritable bowel syndrome an organic disorder? World J Gastroenterol (2014) 1.01
Abnormal propagation pattern of duodenal pressure waves in the irritable bowel syndrome (IBS) [correction of (IBD)]. Dig Dis Sci (2000) 0.98
The colon-selective spasmolytic otilonium bromide inhibits muscarinic M(3) receptor-coupled calcium signals in isolated human colonic crypts. Br J Pharmacol (2002) 0.97
Functional findings in irritable bowel syndrome. World J Gastroenterol (2006) 0.89
Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (review). Int J Mol Med (2014) 0.85
Reduction of colonic motility by intravenous nicardipine in irritable bowel syndrome. Gut (1987) 0.85
Effect of meal ingestion on ileocolonic and colonic transit in health and irritable bowel syndrome. Dig Dis Sci (2010) 0.84
Colonic smooth muscle cells and colonic motility patterns as a target for irritable bowel syndrome therapy: mechanisms of action of otilonium bromide. Therap Adv Gastroenterol (2014) 0.82
Long-term efficacy and safety of otilonium bromide in the management of irritable bowel syndrome: a literature review. Clin Exp Gastroenterol (2014) 0.81
Inner and outer portions of colonic circular muscle: ultrastructural and immunohistochemical changes in rat chronically treated with otilonium bromide. PLoS One (2014) 0.78
Efficacy of otilonium bromide in irritable bowel syndrome: a pooled analysis. Therap Adv Gastroenterol (2017) 0.75
Effect of colonic distension on gastric adaptive relaxation in rats: barostatic evaluation using an orally introduced gastric balloon. J Smooth Muscle Res (2014) 0.75
Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood (2001) 3.84
Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet (2001) 3.28
Twenty four hour manometric recording of colonic motor activity in healthy man. Gut (1987) 2.75
Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia (1995) 1.90
Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc Natl Acad Sci U S A (2001) 1.84
Endoscopic treatment of gastrointestinal fistulas using an over-the-scope clip (OTSC) device: case series from a tertiary referral center. Endoscopy (2011) 1.83
Prevention of cardiac surgery-associated acute kidney injury. Int J Artif Organs (2008) 1.69
1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease. J Am Geriatr Soc (1996) 1.64
Preconditioning effects of levosimendan in coronary artery bypass grafting--a pilot study. Br J Anaesth (2006) 1.64
Increased allergen-specific, steroid-sensitive gamma delta T cells in bronchoalveolar lavage fluid from patients with asthma. Ann Intern Med (1996) 1.61
Gastric acidity and gastroesophageal reflux patterns in patients with esophagitis. Gastroenterology (1992) 1.58
De novo adhesions with extraperitoneal endosurgical para-aortic lymphadenectomy versus transperitoneal laparoscopic para-aortic lymphadenectomy: a randomized experimental study. Am J Obstet Gynecol (2000) 1.55
Manometric investigation of high-amplitude propagated contractile activity of the human colon. Am J Physiol (1988) 1.49
A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group. Gut (2000) 1.48
Quality control study of H2 breath testing for the diagnosis of carbohydrate malabsorption in Italy. The "Tenue Club" Group. Ital J Gastroenterol Hepatol (1997) 1.48
Giardia lamblia infestation reveals underlying Whipple's disease in a patient with longstanding constipation. Am J Gastroenterol (1991) 1.48
Hepatitis B virus antigens in peripheral blood mononuclear cells during the course of viral infection. Clin Immunol Immunopathol (1994) 1.46
Ethanol-specific impairment of T-lymphocyte activation is caused by a transitory block in signal-transduction pathways. Gastroenterology (1993) 1.45
Selective endoscopic retrograde cholangiography and preoperative bile duct stone removal in patients scheduled for laparoscopic cholecystectomy: a prospective study. Am J Gastroenterol (1996) 1.45
[Initial or interval debulking surgery for advanced stage ovarian cancer: state-of-the-art. How to select patients?]. Gynecol Obstet Fertil (2005) 1.44
Chronic inflammation in the pathogenesis of benign prostatic hyperplasia. Int J Androl (2009) 1.43
Antibodies against hepatitis C virus in hemodialysis patients in the central Italian region of Umbria: evaluation of some risk factors. Nephron (1992) 1.41
Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis. Am J Gastroenterol (1990) 1.41
Low incidence of port-site metastases after laparoscopic staging of uterine cancer. Gynecol Oncol (2010) 1.41
Esophageal motor disorders in patients evaluated for dysphagia and/or noncardiac chest pain. Dysphagia (1992) 1.39
Role of robot-assisted laparoscopy in adjuvant surgery for locally advanced cervical cancer. Eur J Surg Oncol (2010) 1.39
[Lymph node dissection in the surgical management of stage I endometrial carcinomas]. Gynecol Obstet Fertil (2003) 1.39
[Complications of laparoscopic lymphadenectomy in gynaecologic oncology. A series of 1102 procedures in 915 patients]. Gynecol Obstet Fertil (2005) 1.39
Intragastric pH monitoring during antisecretory therapy in patient with gastrointestinal bleeding. Am J Gastroenterol (1989) 1.38
Colonic mass movements in idiopathic chronic constipation. Gut (1988) 1.36
NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension. Proc Natl Acad Sci U S A (2001) 1.31
The role of glial cells and apoptosis of enteric neurones in the neuropathology of intractable slow transit constipation. Gut (2005) 1.29
Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release. J Cell Sci (1999) 1.29
Pentoxifylline prevents indomethacin induced acute gastric mucosal damage in rats: role of tumour necrosis factor alpha. Gut (1994) 1.27
Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group. Ann Thorac Surg (2000) 1.26
Coeliac disease: a histological follow-up study. Histopathology (2007) 1.25
Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats. Gastroenterology (1999) 1.24
Enhanced anti-inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats. Gastroenterology (1999) 1.22
Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei. Gastroenterology (1997) 1.22
A new criterion for selection of pharmacokinetic multiexponential equations. J Pharm Sci (1988) 1.19
Modulation of erythrocyte Ca2+-ATPase by selective calpain cleavage of the calmodulin-binding domain. J Biol Chem (1989) 1.18
Laparoscopic restaging of early stage invasive adnexal tumors: a 10-year experience. Gynecol Oncol (2004) 1.17
Gastrointestinal motility disorders in patients with inactive Crohn's disease. Scand J Gastroenterol (1997) 1.17
Twenty-four hour recordings of colonic motility in patients with diverticular disease: evidence for abnormal motility and propulsive activity. Dis Colon Rectum (2001) 1.17
Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. Hum Mol Genet (2000) 1.16
An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity. Proc Natl Acad Sci U S A (2001) 1.14
IL-1 beta converting enzyme is a target for nitric oxide-releasing aspirin: new insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs. J Immunol (2000) 1.14
Extraperitoneal endosurgical aortic and common iliac dissection in the staging of bulky or advanced cervical carcinomas. Cancer (2000) 1.13
Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation. J Immunol (1999) 1.13
NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines. Gastroenterology (2000) 1.13
Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the 'Nutritional Problems in Gastroenterology' Section of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis (2005) 1.13
Method for prolonged ambulatory monitoring of high-amplitude propagated contractions from colon. Am J Physiol (1991) 1.13
Increased colonic motility during exposure to a stressful situation. Dig Dis Sci (1985) 1.11
Enteric nervous system abnormalities in inflammatory bowel diseases. Neurogastroenterol Motil (2008) 1.10
Role of tumor necrosis factor alpha release and leukocyte margination in indomethacin-induced gastric injury in rats. Gastroenterology (1995) 1.10
Antioxidant effect of red wine polyphenols on red blood cells. J Nutr Biochem (2000) 1.09
Esophageal dysfunction in scleroderma: relationship with disease subsets. Arthritis Rheum (1997) 1.09
Biofeedback for pelvic floor dysfunction in constipation. BMJ (2004) 1.09
A post-marketing study on interferon beta 1b and 1a treatment in relapsing-remitting multiple sclerosis: different response in drop-outs and treated patients. J Neurol Neurosurg Psychiatry (2003) 1.08
Hypogonadism and metabolic syndrome. J Endocrinol Invest (2011) 1.07
Gynecomastia during omeprazole therapy. N Engl J Med (1991) 1.07
The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release. FASEB J (2000) 1.06
Prominent role of DT-diaphorase as a cellular mechanism reducing chromium(VI) and reverting its mutagenicity. Cancer Res (1985) 1.05
Prospective evaluation of surgical staging of advanced cervical cancer via a laparoscopic extraperitoneal approach. Gynecol Oncol (2003) 1.05
Celiac disease and Hp infection association in Iran. Rev Esp Enferm Dig (2009) 1.05
Cardiac protection by volatile anesthetics in non-cardiac surgery? A meta-analysis of randomized controlled studies on clinically relevant endpoints. HSR Proc Intensive Care Cardiovasc Anesth (2009) 1.03
Identification of muscarinic receptor subtype mediating colonic response to eating. Dig Dis Sci (1985) 1.03
Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice. Gastroenterology (1996) 1.03
Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome. Tech Coloproctol (2014) 1.02
Pharmacokinetics of 14C-teicoplanin in healthy volunteers. J Antimicrob Chemother (1988) 1.01
Primary enteric neuropathies underlying gastrointestinal motor dysfunction. Scand J Gastroenterol (2000) 1.01
Autonomic dysfunction and upper digestive functional disorders in untreated adult coeliac disease. Eur J Clin Invest (1997) 1.00
Residual insulin secretion at diagnosis of type 1 diabetes is independently associated with both, age of onset and HLA genotype. Diabetes Metab Res Rev (2005) 1.00
Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice. Hepatology (2000) 1.00
False positive EBNA IgM and IgG antibody tests for infectious mononucleosis in children. Pediatrics (1994) 1.00
Clinical and histological features of a group of patients with sporadic non-A, non-B hepatitis. J Clin Pathol (1981) 1.00
Upper gastrointestinal motor activity in patients with slow-transit constipation. Further evidence for an enteric neuropathy. Dig Dis Sci (1996) 0.99
GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice. Gut (2006) 0.99
Pharmacokinetics of glucosamine in man. Arzneimittelforschung (1993) 0.99
Mechanism of non-steroidal anti-inflammatory drug-gastropathy. Dig Liver Dis (2001) 0.98
Protective activity of butyrate on hydrogen peroxide-induced DNA damage in isolated human colonocytes and HT29 tumour cells. Carcinogenesis (2001) 0.98
Effect of omeprazole on gastroesophageal reflux in Barrett's esophagus. Am J Gastroenterol (1989) 0.98
Experience with a new device for pathological assessment of colonic endoscopic submucosal dissection. Tech Coloproctol (2014) 0.98
Upper gastrointestinal motor abnormalities in children with active celiac disease. J Pediatr Gastroenterol Nutr (1995) 0.97
Gastrointestinal motor dysfunction, symptoms, and neuropathy in noninsulin-dependent (type 2) diabetes mellitus. J Clin Gastroenterol (1999) 0.97